Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank43
3Y CAGR-46.0%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-46.0%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$2.19M-44.6%
2024$3.94M-74.6%
2023$15.53M+11.7%
2022$13.91M+219.0%
2021$4.36M-
2020$0.00-
2019$0.00-
2018$0.00-